Mylene Hernandez Remo

Mylene Remo practices at Advocate Illinois Masonic Medical Center in Chicago, Illinois, part of Advocate Health.

Mylene Remo's NPI, 1316236524, was assigned on March 29, 2011. Mylene Remo graduated from University of Chicago, Pritzker School of Medicine in 2011. Mylene Remo holds Illinois license 036.134668.

Mylene Remo's primary practice is Advocate Illinois Masonic Medical Center, at 836 West Wellington Avenue, Chicago, IL 60657 in Cook County. The practice phone is (773) 975-1600.

Mylene Remo's primary practice is Advocate Illinois Masonic Medical Center in Chicago, Illinois, part of Advocate Health. Mylene Remo is also affiliated with Advocate Lutheran General Hospital. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Mylene Remo to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mylene Remo practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Mylene Remo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Mylene Remo is licensed in Illinois.

CMS data shows 551 Medicare services from Mylene Remo across 9 procedure codes in 2024, for 158 Medicare patients. Medicare paid $43,867 for them.

CMS counts 158 Medicare patients who saw Mylene Remo in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mylene Remo's median patient age at 72, with 53% women.

In 2024, Mylene Remo wrote 546 Medicare Part D claims for 89 patients. 69% of them were for generic drugs. CMS names the drug for 425 of them, across 15 drugs with 11 or more claims each, at $730,729 in total drug cost. In 2023, CMS named 286 claims across 13 drugs.

Mylene Remo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mylene Remo as offering telehealth.

Dmand AI links 3 papers to Mylene Remo, published from 2018 to 2021. The most frequent topics are Breast Neoplasms. Mylene Remo's most frequent co-authors are Ivy Elizabeth Abraham, Kent F. Hoskins, MD and Oana Cristina Danciu, MD.

CMS Open Payments shows 328 general payments to Mylene Remo from 43 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 92% of the total. Merck Sharp & Dohme Corporation paid the most, $549.

Mylene Remo graduated from University of Chicago, Pritzker School of Medicine in 2011.